tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Bristol Myers (BMY) and Humana (HUM)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Align Tech (ALGNResearch Report), Bristol Myers (BMYResearch Report) and Humana (HUMResearch Report) with bullish sentiments.

Align Tech (ALGN)

Stephens analyst Chris Cooley maintained a Buy rating on Align Tech today and set a price target of $375.00. The company’s shares closed last Wednesday at $262.61, close to its 52-week low of $225.86.

According to TipRanks.com, Cooley is a 5-star analyst with an average return of 20.8% and a 60.1% success rate. Cooley covers the Healthcare sector, focusing on stocks such as Apollo Endosurgery, Pulse Biosciences, and Cooper Co.

Currently, the analyst consensus on Align Tech is a Strong Buy with an average price target of $365.10, implying a 42.3% upside from current levels. In a report issued on July 14, Stifel Nicolaus also maintained a Buy rating on the stock with a $375.00 price target.

See today’s best-performing stocks on TipRanks >>

Bristol Myers (BMY)

In a report released today, Steve Chesney from Atlantic Equities maintained a Buy rating on Bristol Myers, with a price target of $83.00. The company’s shares closed last Wednesday at $74.81.

According to TipRanks.com, Chesney is a 2-star analyst with an average return of 2.1% and a 58.3% success rate. Chesney covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Merck & Company, and Eli Lilly & Co.

Bristol Myers has an analyst consensus of Moderate Buy, with a price target consensus of $78.77, an 8.8% upside from current levels. In a report issued on July 15, Berenberg Bank also maintained a Buy rating on the stock with a $82.00 price target.

Humana (HUM)

SVB Securities analyst Whit Mayo maintained a Buy rating on Humana today and set a price target of $540.00. The company’s shares closed last Wednesday at $478.35, close to its 52-week high of $497.47.

According to TipRanks.com, Mayo is a 5-star analyst with an average return of 9.2% and a 57.4% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Alignment Healthcare, and Privia Health Group.

Currently, the analyst consensus on Humana is a Strong Buy with an average price target of $529.58, implying an 8.6% upside from current levels. In a report issued on July 14, Jefferies also maintained a Buy rating on the stock with a $560.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ALGN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More